At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
Lovaza (omega-3-acid ethyl esters) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers
In Brief
A Phase 2 clinical trial evaluating Lovaza (omega-3-acid ethyl esters) and Wheat Germ Oil for Muscle Damage and Muscle Inflammation. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the effects of fish oil supplementation (Lovaza, GlaxoSmithKline) on muscle strength, muscle soreness and inflammation following exercise.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Damage, Muscle Inflammation
CountriesUnited States
CollaboratorsGlaxoSmithKline
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 2008
Enrollment StartMar 2009
Primary CompletionDec 2009
Study CompletionFeb 2010
TodayJul 2026
First PostedDec 10, 2008
Enrollment StartMar 1, 2009
Primary CompletionDec 1, 2009
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.6 years ago
Interventions
Lovaza (omega-3-acid ethyl esters)drug
Lovaza, 3 grams per day for 65 days
Wheat Germ Oildrug
Wheat germ oil, 3 grams/day for 65 days